'Bubble Time' in Pulmonary Embolism

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-07-03

Study Completion Date

2025-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will be multi-centre and prospectively planned. All patients who undergo contrast-enhanced computed tomography in the emergency department with a preliminary diagnosis of pulmonary embolism and who do not meet the exclusion criteria will be included in the study. Informed consent will be obtained from all patients prior to the study. Patients included in the study will undergo bedside ultrasound to assess bubble time, right ventricle-left ventricle ratio, presence of a septal defect, and tricuspid insufficiency, and the diagnostic value of these findings will be evaluated. The bedside ultrasound will be part of the emergency department critical care examination, will not incur any costs for the institution, and will be performed and evaluated by an emergency medicine specialist and assistant.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Using End-Tidal CO₂ to Help Diagnose and Monitor Pulmonary Embolism

NCT07241130

Pulmonary Embolism Acute

COMPLETED

Early Systolic Notching in Pulmonary Embolism

NCT04413825

Pulmonary Embolism

COMPLETED

Thrombus Localization and Accompaying Disorders and Risk Factors

NCT02388841

Pulmonary Embolism

COMPLETED

Surfactant Associated Protein - A Novel Marker for the Diagnosis of Pulmonary Embolism

NCT01353365

Pulmonary Embolism

UNKNOWN

Pulmonary Embolism and COVID-19

NCT04590378

Covid-19 Pulmonary Embolism

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will be multi-centre and prospectively planned. All patients who undergo contrast-enhanced computed tomography in the emergency department with a preliminary diagnosis of pulmonary embolism and who do not meet the exclusion criteria will be included in the study. Informed consent will be obtained from all patients prior to the study. Patients included in the study will undergo bedside ultrasound to assess bubble time, right ventricle-left ventricle ratio, presence of a septal defect, and tricuspid insufficiency, and the diagnostic value of these findings will be evaluated. The bedside ultrasound will be part of the emergency department critical care examination, will not incur any costs for the institution, and will be performed and evaluated by an emergency medicine specialist and assistant.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tanısal değerlilik

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- All patients presenting to the emergency department with any symptoms, undergoing pulmonary CT angiography due to suspected pulmonary embolism or evaluated as having a strong likelihood of embolism when CT cannot be performed will be included in the study.

Exclusion Criteria

* Patients under the age of 18
* Patients with a severe history of tricuspid insufficiency
* Patients with a severe of pulmonary hypertension
* Patients with a severe of right heart failure
* Patients without an echocardiographic report approved by cardiology within 48 hours after emergency admission
* Patients in whom ultrasonographic measurements cannot be performed
* Patients who refuse diagnosis and treatment voluntarily

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No